Jane Street
KZIA

Jane Street’s Kazia Therapeutics KZIA Stock Holding History

Jane Street’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-922
Closed -$19.8K – 10041
2024
Q3 		$19.8K Buy
+922
New +$18.4K ﹤0.01% 9294
2015
Q3 		– Sell
-54
Closed -$44K – 3902
2015
Q2 		$44K Sell
54
-68
-56% -$77.2K ﹤0.01% 3524
2015
Q1 		$105K Sell
122
-163
-57% -$93.5K ﹤0.01% 2995
2014
Q4 		$118K Buy
+285
New +$141K ﹤0.01% 2320

Other funds holding KZIA

MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Jane Street's KZIA Position: Q4 2024 in Review

Jane Street sold out of Kazia Therapeutics (KZIA) in Q4 2024, closing a stake of 922 shares — an estimated $19.8K sold.

Jane Street first reported a position in KZIA in Q4 2014 and held it in 4 quarters. The position peaked at $118K in Q4 2014. 10 funds tracked by Wall St. Rank hold KZIA as of Q4 2024.

  • Jane Street reported no remaining Kazia Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Jane Street sold 922 Kazia Therapeutics shares in Q4 2024, an estimated $19.8K.
  • Jane Street first reported a position in Kazia Therapeutics in Q4 2014 and held it in 4 quarters.
  • Jane Street's Kazia Therapeutics position peaked at $118K in Q4 2014.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2024.

Based on Jane Street's 13F filing for Q4 2024, filed 14 Feb 2025.